ASD Clinical Trial
— IRM-ETOfficial title:
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
Most studies use static visual percepts that are less representative of joint attention versus an ecological environment. This has the consequence of decreasing the perception of an interaction with a social partner, which is an essential step in achieving joint attention. The originality of this study is to improve the design of visual percepts (in the form of video) in order to mimic an ecological environment as much as possible by using MRI-ET coupling. The second originality of this study is the longitudinal exploration of the neurodevelopment of social cognition in autistic children. Studies by the Redcay and Oberwelland teams observe different activations at different ages. The hypothesis is that the perception of joint attention varies over time in people with ASD. To date, there are no studies to determine the influence of childhood neurodevelopment in autistic people on the perception of joint attention. It would be unprecedented to use the MRI-ET pairing as a tool for assessing social cognition as a function of the development of children with ASD.
Status | Recruiting |
Enrollment | 68 |
Est. completion date | May 2024 |
Est. primary completion date | January 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 10 Years to 20 Years |
Eligibility | Inclusion Criteria: For the group of people with Autism Spectrum Disorders (experimental group): - Age between 10 to 20 years old - Diagnosis of ASD (CARS) = 30 performed at inclusion - IQ test evaluation (regardless of the result) performed by a trained psychologist - Obtaining informed oral and written consent after appropriate information - Obtaining informed oral and written consent from the legal guardian after information - Be affiliated with social security - No contraindication to magnetic resonance imaging For the TD (Typical Development) group of people (control group): - Age between 10 to 20 years old - Diagnosis of ASD (CARS) <30 performed at inclusion - IQ test evaluation (regardless of the result) performed by a trained psychologist - Obtaining informed oral and written consent after appropriate information - Obtaining informed oral and written consent from the legal guardian after information - Be affiliated with social security - No contraindication to magnetic resonance imaging Exclusion Criteria: For all groups: - Age outside the range 10 to 20 years - Person with a contraindication to MRI (including claustrophobia, pace maker, neurosurgical clips, vascular clips, heart valves, ventriculoperitoneal valves, cochlear implant, neurostimulator, intraocular metal shards, joint prosthesis, etc.) - Person suffering from major obesity (> 140 kg) not allowing him to enter the tunnel of the MRI machine (diameter <70cm) - Pregnant or breastfeeding woman - Person under guardianship or guardianship or deprived of liberty by a judicial or administrative decision For TD people (control group): - Person with psychiatric disorders such as attention disorder with or without hyperactivity, depression, bipolar disorder and schizophrenia. - Person with a neurological history such as epilepsy and / or neurovascular accident. |
Country | Name | City | State |
---|---|---|---|
France | CHU Amiens Picardie | Amiens | Picardie |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire, Amiens |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | difference of mapping IRM-ET results between both patient groups | both patient groups are : the group of people with Autism Spectrum Disorders and Typical Development group of people | one day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT04771338 -
Examining the Effects of a Job Entry Intervention
|
N/A | |
Completed |
NCT04178421 -
Computerized Eye-tracking Attention Training for Children With Special Needs
|
N/A | |
Completed |
NCT02985749 -
A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
|
Phase 3 | |
Recruiting |
NCT06012903 -
Lower Urinary Tract Symptoms and School Functioning in Children
|
||
Not yet recruiting |
NCT04418921 -
Improving Self-regulation in Children With Neurodevelopmental Disorders:
|
N/A | |
Completed |
NCT01931033 -
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
|
N/A | |
Recruiting |
NCT04899544 -
Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism
|
N/A | |
Recruiting |
NCT06155214 -
Developmental Regression-related Disease Research and Achievement Transformation Innovation Team
|
||
Active, not recruiting |
NCT01932515 -
Diagnostic Instruments for Autism in Deaf Children Study
|
N/A | |
Recruiting |
NCT06188429 -
Peripheral Blood VA/TREM2 Levels and Their Correlation Analysis With the Development and Autistic Symptoms in Children With ASD
|
||
Completed |
NCT06209463 -
Posture, Hand Functions and Sensory Processing Skills on Nutrition
|
||
Recruiting |
NCT06155201 -
Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders
|
N/A | |
Recruiting |
NCT03502239 -
Cognitive Rehabilitation (Mega Team) and Its Effects on Emotional and Behavioral Regulation in ADHD, ASD, and CHD
|
N/A | |
Withdrawn |
NCT03829878 -
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)
|
Phase 2 | |
Recruiting |
NCT02461446 -
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
|
||
Completed |
NCT03900923 -
Cannabidiol for ASD Open Trial
|
Phase 2 | |
Recruiting |
NCT06339359 -
A Pilot Study to Develop a Behavior-based Screening Protocol for Early Diagnosis of Autism Spectrum Disorders
|
||
Completed |
NCT03099239 -
hCT-MSCs for Children With Autism Spectrum Disorder (ASD)
|
Phase 1 |